Brind.

Incepta Pharmaceuticals and BioCryst Pharmaceuticals were ranked in the Medical – Drugs industry as of August 13, 2025.

1 report, 1 independent Updated Aug 13

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Incepta Pharmaceuticals BioCryst Pharmaceuticals

Keep exploring

The entities involved

Incepta Pharmaceuticals
incepta
- Tilray Brands, Inc.'s stock change lagged the S&P 500 gain on August 28, 2025, while the company holds a Zacks Rank of #3.Sun 03:24
- Precision BioSciences and Incepta Pharmaceuticals were noted as belonging to a specified industry in August 2025.Sat 20:39
BioCryst Pharmaceuticals
American pharmaceutical company

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 13ZacksAre Options Traders Betting on a Big Move in BCRX Stock? Investors in BioCryst Pharmaceuticals BCRX need to pay close attention to the stock based on moves in the options market lately. That is becau